Teleflex Inc
NYSE:TFX

Watchlist Manager
Teleflex Inc Logo
Teleflex Inc
NYSE:TFX
Watchlist
Price: 177.26 USD -0.56% Market Closed
Market Cap: 8.2B USD
Have any thoughts about
Teleflex Inc?
Write Note

Net Margin
Teleflex Inc

7.9%
Current
13%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
7.9%
=
Net Income
237.4m
/
Revenue
3B

Net Margin Across Competitors

Country US
Market Cap 8.2B USD
Net Margin
8%
Country US
Market Cap 199B USD
Net Margin
14%
Country US
Market Cap 191.3B USD
Net Margin
29%
Country US
Market Cap 141.3B USD
Net Margin
16%
Country US
Market Cap 134.2B USD
Net Margin
11%
Country IE
Market Cap 104.6B USD
Net Margin
13%
Country US
Market Cap 65.6B USD
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Net Margin
8%
Country US
Market Cap 44.5B USD
Net Margin
74%
Country CN
Market Cap 310B CNY
Net Margin
33%
Country US
Market Cap 36.3B USD
Net Margin
9%
No Stocks Found

Teleflex Inc
Glance View

Market Cap
8.2B USD
Industry
Health Care
Economic Moat
None

In the world of medical technology, Teleflex Inc. emerges as a nuanced, multifaceted player, crafting a narrative not just of survival, but of steady growth through innovation and strategic vision. Founded in the allure of post-war optimism in 1943, Teleflex began its journey in the aerospace and marine industries. However, recognizing the steadily aging global population and increasing healthcare demands, the company pivoted towards the medical sector, a decision that has since defined its contemporary identity. Teleflex now thrives as a diversified global provider of medical technologies designed to improve health and the quality of people's lives. It specializes in critical care and surgical solutions, focusing its efforts on areas like vascular access, anesthesia, respiratory care, and urology, among others. Teleflex Inc. crafts its financial landscape through a robust combination of product innovation, strategic acquisitions, and a strong global footprint. Their revenue streams are primarily derived from selling medical devices and equipment to healthcare providers worldwide. A significant competitive edge lies in its ability to consistently introduce new products that address unmet clinical needs while enhancing patient safety and outcomes. This focus is evident in their Research and Development initiatives, which are integral to maintaining their market position. Moreover, by acquiring companies with complementary technologies and market reach, Teleflex continually broadens its portfolio, navigating the complex and evolving healthcare landscape with finesse and agility. Through these strategic maneuvers, the company ensures a steady flow of revenue that aligns with global healthcare trends and demands.

TFX Intrinsic Value
276.95 USD
Undervaluation 36%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
7.9%
=
Net Income
237.4m
/
Revenue
3B
What is the Net Margin of Teleflex Inc?

Based on Teleflex Inc's most recent financial statements, the company has Net Margin of 7.9%.